|
Effects of Aerobic Exercise Intensity on Clinical & Neural Outcomes in Depressed Youth
RECRUITINGN/ASponsored by The Royal's Institute of Mental Health Research
Actively Recruiting
PhaseN/A
SponsorThe Royal's Institute of Mental Health Research
Started2018-08-07
Est. completion2025-09-01
Eligibility
Age16 Years – 24 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04110041
Summary
This study will assess the effects of moderate vs. high intensity aerobic exercise, performed 3 times a week for 12 weeks under supervised conditions, on symptoms of depression, cognitive functioning and brain function in transitional aged youth (TAY: aged 16-24 years).
Eligibility
Age: 16 Years – 24 YearsHealthy volunteers accepted
Inclusion Criteria: * Currently experiencing depression (MDD or PDD); * Free of pharmacotherapy (ie. antidepressant medication) for \>5 weeks; * Not currently engaging in regular moderate or vigorous intensity exercise; * Able to read/understand English; * Body mass index \[BMI\] \< 40; * Medically cleared to engage in aerobic exercise. Exclusion Criteria: * Currently engaged in another exercise trial; * Another Axis I/II DSM-5 disorder, apart from co-morbid anxiety disorder(s); * Current or lifetime history of serious medical or neurological conditions; * Currently taking psychoactive drugs (occasional use of anti-anxiety medication permitted); * Regular user of nicotine products; * Unstable medical conditions, especially those that prevent exercise; * Exhibiting significant suicide risk; * MRI contraindications; * Currently pregnant or breastfeeding.
Conditions1
Depression
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorThe Royal's Institute of Mental Health Research
Started2018-08-07
Est. completion2025-09-01
Eligibility
Age16 Years – 24 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04110041